1. Home
  2. ITOS vs STRS Comparison

ITOS vs STRS Comparison

Compare ITOS & STRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • STRS
  • Stock Information
  • Founded
  • ITOS 2011
  • STRS 1992
  • Country
  • ITOS United States
  • STRS United States
  • Employees
  • ITOS N/A
  • STRS N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • STRS Homebuilding
  • Sector
  • ITOS Health Care
  • STRS Real Estate
  • Exchange
  • ITOS Nasdaq
  • STRS Nasdaq
  • Market Cap
  • ITOS 381.2M
  • STRS 155.7M
  • IPO Year
  • ITOS 2020
  • STRS N/A
  • Fundamental
  • Price
  • ITOS $10.34
  • STRS $19.05
  • Analyst Decision
  • ITOS Hold
  • STRS
  • Analyst Count
  • ITOS 6
  • STRS 0
  • Target Price
  • ITOS $10.60
  • STRS N/A
  • AVG Volume (30 Days)
  • ITOS 793.1K
  • STRS 22.1K
  • Earning Date
  • ITOS 08-07-2025
  • STRS 08-12-2025
  • Dividend Yield
  • ITOS N/A
  • STRS N/A
  • EPS Growth
  • ITOS N/A
  • STRS N/A
  • EPS
  • ITOS N/A
  • STRS N/A
  • Revenue
  • ITOS $35,000,000.00
  • STRS $32,719,000.00
  • Revenue This Year
  • ITOS N/A
  • STRS N/A
  • Revenue Next Year
  • ITOS N/A
  • STRS N/A
  • P/E Ratio
  • ITOS N/A
  • STRS N/A
  • Revenue Growth
  • ITOS 177.89
  • STRS N/A
  • 52 Week Low
  • ITOS $4.80
  • STRS $15.10
  • 52 Week High
  • ITOS $18.13
  • STRS $30.66
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 66.97
  • STRS 49.58
  • Support Level
  • ITOS $10.05
  • STRS $18.80
  • Resistance Level
  • ITOS $10.21
  • STRS $21.01
  • Average True Range (ATR)
  • ITOS 0.13
  • STRS 1.10
  • MACD
  • ITOS -0.06
  • STRS 0.07
  • Stochastic Oscillator
  • ITOS 81.48
  • STRS 42.29

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About STRS Stratus Properties Inc.

Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.

Share on Social Networks: